Search for tag: "bioavailability"

Nanoparticle Delivery of Delamanid for Cost-effective Treatment of Tuberculosis, Satya K Nayagam, UG '22 (2310833)

Tuberculosis remains a major health issue in the world today with over 10 million cases a year. Delamanid (Deltyba) is a new drug for the treatment of multidrug-resistant TB that was approved in…

From  Research Princeton Research Day on April 29th, 2021 4 likes 105 plays